SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-16-012129
Filing Date
2016-04-12
Accepted
2016-04-12 17:05:16
Documents
6
Period of Report
2016-05-26

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2228231zpre14a.htm PRE 14A 399275
2 G427526.JPG g427526.jpg GRAPHIC 11748
3 G5970.JPG g5970.jpg GRAPHIC 9084
4 G443112.JPG g443112.jpg GRAPHIC 6659
5 G24212BEI001.GIF g24212bei001.gif GRAPHIC 92750
6 G24212BEI002.GIF g24212bei002.gif GRAPHIC 74940
  Complete submission text file 0001047469-16-012129.txt   669663
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37350 | Film No.: 161567785
SIC: 3841 Surgical & Medical Instruments & Apparatus